Cynthia I Campbell1, Amber L Bahorik2, Andrea H Kline-Simon3, Derek D Satre2. 1. Division of Research, Kaiser Permanente, Northern California, Oakland, CA, 94612-2304, USA; Department of Psychiatry, UCSF Weill Institute for Neurosciences, University of California, San Francisco, 401 Parnassus Avenue, Box 0984, San Francisco, CA 94143, USA. Electronic address: cynthia.i.campbell@kp.org. 2. Division of Research, Kaiser Permanente, Northern California, Oakland, CA, 94612-2304, USA; Department of Psychiatry, UCSF Weill Institute for Neurosciences, University of California, San Francisco, 401 Parnassus Avenue, Box 0984, San Francisco, CA 94143, USA. 3. Division of Research, Kaiser Permanente, Northern California, Oakland, CA, 94612-2304, USA.
Abstract
BACKGROUND: Marijuana use disorder (MUD) is the most common illegal drug use disorder and its prevalence is increasing. It is associated with psychiatric and medical problems, but little is known about its impact on emergency department (ED) and inpatient utilization rates. DESIGN: In a retrospective cohort design, we used electronic health record (EHR) data to identify patients with MUD (n=2752) and demographically matched patients without MUD (n=2752) in 2010. Logistic regressions determined risk of ED and inpatient visits each year from 2010 to 2014 for MUD patients versus controls; mixed-effect growth models examined differences in utilization rates over 5-years. Patient characteristics predicting increased risk of utilization were examined among the MUD sample only. KEY RESULTS: Rates of ED (OR=0.87, p<0.001) and inpatient (OR=0.76, p<0.001) services use significantly declined over 5 years for all patients. Patients with MUD exhibited a significantly greater decline in ED (OR=0.81, p<0.001) and inpatient (OR=0.64, p<0.001) use relative to controls. However, MUD patients had significantly greater risk of having ED and inpatient visits at each time point (p's<0.001). MUD patients with co-occurring other substance use, medical, and/or psychiatric disorders had a greater risk of having ED or inpatient encounters over 5 years (p's<0.001). CONCLUSIONS: MUD patients remain at high risk for ED and inpatient visits despite decreasing utilization rates over 5 years. Addressing MUD patients' comorbid conditions in outpatient settings may help reduce inappropriate service use.
BACKGROUND:Marijuana use disorder (MUD) is the most common illegal drug use disorder and its prevalence is increasing. It is associated with psychiatric and medical problems, but little is known about its impact on emergency department (ED) and inpatient utilization rates. DESIGN: In a retrospective cohort design, we used electronic health record (EHR) data to identify patients with MUD (n=2752) and demographically matched patients without MUD (n=2752) in 2010. Logistic regressions determined risk of ED and inpatient visits each year from 2010 to 2014 for MUD patients versus controls; mixed-effect growth models examined differences in utilization rates over 5-years. Patient characteristics predicting increased risk of utilization were examined among the MUD sample only. KEY RESULTS: Rates of ED (OR=0.87, p<0.001) and inpatient (OR=0.76, p<0.001) services use significantly declined over 5 years for all patients. Patients with MUD exhibited a significantly greater decline in ED (OR=0.81, p<0.001) and inpatient (OR=0.64, p<0.001) use relative to controls. However, MUD patients had significantly greater risk of having ED and inpatient visits at each time point (p's<0.001). MUD patients with co-occurring other substance use, medical, and/or psychiatric disorders had a greater risk of having ED or inpatient encounters over 5 years (p's<0.001). CONCLUSIONS: MUD patients remain at high risk for ED and inpatient visits despite decreasing utilization rates over 5 years. Addressing MUD patients' comorbid conditions in outpatient settings may help reduce inappropriate service use.
Authors: Theresa H M Moore; Stanley Zammit; Anne Lingford-Hughes; Thomas R E Barnes; Peter B Jones; Margaret Burke; Glyn Lewis Journal: Lancet Date: 2007-07-28 Impact factor: 79.321
Authors: Gwen T Lapham; Cynthia I Campbell; Bobbi Jo H Yarborough; Rulin C Hechter; Brian K Ahmedani; Irina V Haller; Andrea H Kline-Simon; Derek D Satre; Amy M Loree; Constance Weisner; Ingrid A Binswanger Journal: Subst Abus Date: 2019-01-18 Impact factor: 3.716
Authors: Derek D Satre; Sujaya Parthasarathy; Kelly C Young-Wolff; Meredith C Meacham; Brian Borsari; Matthew E Hirschtritt; Lucas Van Dyke; Stacy A Sterling Journal: J Stud Alcohol Drugs Date: 2022-09 Impact factor: 3.346
Authors: Theresa E Matson; Gwen T Lapham; Jennifer F Bobb; Eric Johnson; Julie E Richards; Amy K Lee; Katharine A Bradley; Joseph E Glass Journal: Drug Alcohol Depend Date: 2020-08-08 Impact factor: 4.492
Authors: Amber L Bahorik; Cynthia I Campbell; Stacy A Sterling; Amy Leibowitz; Adam Travis; Constance M Weisner; Derek D Satre Journal: Psychiatry Res Date: 2017-10-19 Impact factor: 3.222
Authors: Dan Lewer; Joseph Freer; Emma King; Sarah Larney; Louisa Degenhardt; Emily J Tweed; Vivian D Hope; Magdalena Harris; Tim Millar; Andrew Hayward; Dan Ciccarone; Katherine I Morley Journal: Addiction Date: 2020-02-10 Impact factor: 7.256
Authors: Andrea H Weinberger; Jonathan Platt; Jiaqi Zhu; Jacob Levin; Ollie Ganz; Renee D Goodwin Journal: J Clin Psychiatry Date: 2021-06-29 Impact factor: 5.906